Geron
4 followers
‌
Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.
Industries
Headquarters
Employees
Links
Org chart
John A. Scarlett
Chairman, President & CEO
John A. Scarlett
Collapse
Andrew J. Grethlein
EVP & COO
Edward Koval
EVP & Chief Business Officer
Michelle Robertson
Executive Vice President, CFO & Treasurer
Melissa A. Kelly Behrs
EVP, Business Operations & Chief Alliance Officer
Faye Feller
EVP, Chief Medical Officer
Jim Ziegler
EVP & Chief Commercial Officer
Joseph Eid
EVP, Research & Development
Scott A. Samuels
EVP, CLO & Corporate Secretary
Nishan Sengupta
Vice President-market Access, Pricing, Evidence Strategy
Scott Hutson
Vice President Of Sales
Ryan Vincenti
Associate Director Of Commercial Excellence
